Global Small Animal Imaging
(In-Vivo) market is expected to reach USD 2.7 billion by 2022, according to a
new study by Grand View Research, Inc. Growing number of medical conditions
requiring accurate research for development of treatment options is expected to
enhance demand for small animal imaging (in-Vivo) over the forecast period.
Importance of these devices in applications such as epigenetic research
studies, drug receptor targeting, and defining mechanism of action is estimated
to provide potential growth platform for this industry. The major factors
driving the growth of small animal imaging (in-vivo) market are growing usage
of multi-functional pre-clinical imaging, rising investments of CROs in
pre-clinical studies, increasing number of pharmaceutical and research
organizations and technical innovations such as high-resolution MRI with other
modalities.
In depth research report on Small Animal Imaging (In-vivo)
Market
Further key findings from the study suggest:
·
Optical imaging dominated the
technology segment in 2014 in terms of revenue share of over 45%. Advantages
associated with this technology such as easy and rapid operations and
relatively lower costs compared to other devices are the factors attributing
for its high share.
·
Micro-MRI technology is
expected to be the fastest growing, and is expected to grow at a lucrative CAGR
of over 12.0% by 2022. Micro-MRI has wide applications during functional and anatomical
analysis in developing mouse neonates and embryos.
·
In term of applications,
monitoring treatment response, bio-distribution, cancer cell detection,
biomarkers, longitudinal studies and epigenetic studies are segments studied.
In 2014, Bio-distribution and monitoring the treatment response dominated the
overall market in terms of revenue share of over 33% and 25% respectively.
·
The cancer cell detection
segment is expected to show prominent growth rate owing to the rising global
prevalence of cancer, and increasing government initiatives pertaining to
cancer diagnostics research. Cancer cell detection application is expected to
generate revenue of over USD 700 million by 2022, at a CAGR of over 12% from
2015 to 2022.
·
North America dominated in terms
of revenue in 2014 at 36.1% in 2014. Favorable platform for R&D pertaining
to technological advancements, vast pre-clinical research, established
healthcare infrastructure, and rising demand for rapid and advanced methods are
the key factors attributing for the highest revenue generation in this region.
European market held the second position owing to the large number of
pharmaceutical and clinical research organizations and diagnostic device
manufacturers.
·
Asia Pacific regional market is
expected to register significant growth over the forecast period with CAGR of
over 11% owing to emerging economies, growing base of target population, and
growing clinical research activities. Additionally, rising acceptance level for
advanced medical devices is expected to provide potential growth platform for
key players of this market.
·
The key players in this
industry include Thermo Fisher Scientific, Inc. Siemens AG, Mediso Medical
Imaging Systems, Life Technologies Corporation, Promega Corporation, Miltenyi
Biotech GmbH, Bruker Corporation, FujiFilm Holding Corporation, PerkinElmer Inc.
and Aspect Imaging Ltd. Companies are developing novel products to sustain
their market positions. For instance, Bruker Corporation has launched SKYSCAN
1176, In-vivo micro-CT, and Wrist MRI Machine from Aspect for effortless
imaging.
Grand View Research has
segmented the global small animal imaging (In-Vivo) market on the basis of
medium and region:
Global
Small Animal Imaging (In-Vivo) Technology Outlook (Revenue, USD Million, 2012 -
2022)
·
Micro-magnetic resonance
imaging
·
Optical imaging
·
Nuclear imaging
·
Other imaging modalities
Global Small Animal Imaging (In-Vivo) Application Outlook
(Revenue, USD Million, 2012 - 2022)
·
Monitoring treatment
responseCancer cell detection
·
Bio-distribution
·
Biomarkers
·
Longitudinal studies
·
Epigenetics
Small Animal Imaging (In-Vivo) Regional Outlook (Revenue,
USD Million, 2012 - 2022)
·
North America
·
Europe
·
Asia Pacific
·
RoW
Browse more research reports of this category:
About Grand View Research
Grand View Research, Inc. is a
U.S. based market research and consulting company, registered in the State of
California and headquartered in San Francisco. The company provides syndicated
research reports, customized research reports, and consulting services. To help
clients make informed business decisions, the company offers market
intelligence studies ensuring relevant and fact-based research across a range
of industries including technology, chemicals, materials, healthcare and
energy.
For more market analysis reports, please visit: http://www.grandviewresearch.com/
No comments:
Post a Comment